Plus, news about Merus, Supernus and Verrica:
Syndax Pharmaceuticals’ $350M deal with Royalty Pharma: The agreement is based on US sales …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Ryne Natzke, Chief Revenue Officer, TrustCommerce, a Sphere Company If you’ve ever worked behind the scenes at a provider organization, you likely gained a deep
While everyone was preparing to head to Wonderland Miami, the psychedelic space saw a week full of debates! From the FDA’s recommendation to limit psychological
After seven months on the market, Regeneron’s Eylea HD is already making strides with ophthalmologists. According to Spherix Global Insights’ research, 81% of ophthalmologists who